Cargando…

Splanchnic Haemodynamics and Vasoactive Agents in Experimental Cirrhosis

It is well known that portal hypertension is associated with a hyperdynamic systemic circulatory state. This study measures systemic and splanchnic haemodynamics in an experimental rat model of hepatic cirrhosis. It also investigates the association between haemodynamic changes in cirrhotic animals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geraghty, J. G., Angerson, W. J., Carter, D. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423761/ https://www.ncbi.nlm.nih.gov/pubmed/7880777 http://dx.doi.org/10.1155/1994/52975

Ejemplares similares

Splanchnic blood flow changes in the presence of hepatic tumour: evidence of a humoral mediator.
por: Carter, R., et al.
Publicado: (1994)

Splanchnic and haemodynamic data as prognostic indexes in MODS patients
por: Ruggieri, CG, et al.
Publicado: (1999)

Erosive Gastritis and Portal Hypertension
por: Geraghty, J. G., et al.
Publicado: (1992)

Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis
por: Senzolo, Marco, et al.
Publicado: (2018)

Splanchnic Vein Thrombosis in Cirrhosis − Areas Still in the Shadow
por: Gîrleanu, Irina, et al.
Publicado: (2018)

Involvement of vasoactive substances in hemodynamics disturbances in cirrhosis
por: Grancea-Iancu, M
Publicado: (2014)

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure
por: Laleman, Wim, et al.
Publicado: (2006)

Splanchnic Analgesia
por: Wood, W. Q.
Publicado: (1927)

Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
por: Siemann, D. W.
Publicado: (1990)

Duplex/colour Doppler sonography: measurement of changes in hepatic arterial haemodynamics following intra-arterial angiotensin II infusion.
por: Leen, E., et al.
Publicado: (1993)

Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
por: Stratford, I. J., et al.
Publicado: (1988)

An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agent
por: Su, Er-Ning, et al.
Publicado: (2012)

Human splanchnic amino-acid metabolism
por: Neis, Evelien P. J. G., et al.
Publicado: (2016)

Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2017)

Epinephrine: Is it really the black sheep of vasoactive agents?
por: Agrawal, Ritwick, et al.
Publicado: (2010)

Control of the Splanchnic Circulation
por: Jacobson, Eugene D.
Publicado: (1977)

Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow.
por: Dworkin, M. J., et al.
Publicado: (1997)

Timing of vasoactive agents and corticosteroid initiation in septic shock
por: Ammar, Mahmoud A., et al.
Publicado: (2022)

Thyroid and Hepatic Haemodynamic Alterations among Egyptian Children with Liver Cirrhosis
por: El-Kabbany, Zeinab A., et al.
Publicado: (2012)

Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial
por: Mahdy, Magdy Mohammed, et al.
Publicado: (2019)

Patterns of renal and splanchnic sympathetic vasomotor activity in an animal model of survival to experimental sepsis
por: Milanez, M.I.O., et al.
Publicado: (2022)

Novocain and Splanchnic Anæsthesia
por: Murray, H. E.
Publicado: (1931)

STUDIES ON EXPERIMENTAL HYPERTENSION : II. THE EFFECT OF RESECTION OF SPLANCHNIC NERVES ON EXPERIMENTAL RENAL HYPERTENSION
por: Goldblatt, Harry, et al.
Publicado: (1937)

Systemic and Splanchnic Lipopolysaccharide and Endothelin-1 Plasma Levels in Liver Cirrhosis before and after Transjugular Intrahepatic Portosystemic Shunt
por: Meng, Jiaxiang, et al.
Publicado: (2016)

Management of splanchnic vein thrombosis
por: Elkrief, Laure, et al.
Publicado: (2023)

Clinical review: Splanchnic ischaemia
por: Jakob, Stephan M
Publicado: (2002)

Adrenomedullin: A vasoactive agent for sporadic and hereditary vascular cognitive impairment
por: Ihara, Masafumi, et al.
Publicado: (2021)

Use of vasoactive agents in non‐cardiac surgery: Protocol for a scoping review
por: Bækgaard, Emilie S., et al.
Publicado: (2022)

The effects of vasopressin infusion on hepatic haemodynamics in an experimental model of liver metastases.
por: Hemingway, D. M., et al.
Publicado: (1991)

Imaging Diagnosis of Splanchnic Venous Thrombosis
por: Rajesh, S., et al.
Publicado: (2015)

The effects of sandostatin (Octreotide, SMS 201-995) infusion on splanchnic and hepatic blood flow in an experimental model of hepatic metastases.
por: Hemingway, D. M., et al.
Publicado: (1992)

Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort
por: Villa, Pia M, et al.
Publicado: (2013)

On Hæmodynamics
por: Griffiths, W. Handsel
Publicado: (1868)

Symposium on Hæmodynamics in Pregnancy. v. Hæmodynamics in Pregnancy
por: Kellar, Robert J.
Publicado: (1950)

Neural control of inflammation by the greater splanchnic nerves
por: Martelli, Davide, et al.
Publicado: (2014)

Splanchnic Vein Thrombosis: Current Perspectives
por: Valeriani, Emanuele, et al.
Publicado: (2019)

A brief report on the effects of vasoactive agents on peripheral venous waveforms in a porcine model
por: Polcz, Monica, et al.
Publicado: (2020)

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
por: Manji, Farheen, et al.
Publicado: (2017)

Vasoactive agents in acute mesenteric ischaemia in critical care. A systematic review
por: Brennan, Christopher A, et al.
Publicado: (2021)

Splanchnic Nerve Ablation for Volume Management in Heart Failure
por: Fudim, Marat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8d541qqmuarh93kbe1nssnh5at